Ofir Arad

Teledyne LeCroy, Inc. provides oscilloscopes and protocol analyzers. Its products include oscilloscopes, protocol analysers, waveform generators, logic analyzers, optical modulation analyzer, and signal integrity studio. The company was founded by Walter LeCroy in 1964 and is headquartered in Chestnut Ridge, NY.

Part of DAIKIN INDUSTRIES Ltd., InControl, Inc. manufactures heating, ventilation and air conditioning equipment. The company is based in Redmond, WA. The company was founded in 1990 by Kurt C. Wheeler, John M. Adams, Clifton A. Alferness, Michel E. Lussier. InControl was acquired by AirReps LLC from Boston Scientific Corp. on July 10, 2023.

Johnson & Johnson Consumer, Inc. manufactures health and skin care products. It offers wide variety of lotion, moisturizing cream, baby wash, shampoo and conditioner, baby powder and bath, hand and face wipes, soap, baby oil and cologne. The company was founded on March 8, 2016 and is headquartered in Skillman, NJ.

Acrostak Corp. is a Swiss company that specializes in medical devices for interventional cardiology. The private company is based in Geneva, Switzerland. The company's focus is on chronic total occlusion and they offer PTCA balloons and percutaneous coronary intervention devices.

e-EyeCare GmbH operates an online ophthalmology portal. The private company is based in Erlangen, Germany.

Value Italy SGR SpA (Value Italy) is an independent private equity firm founded in 2001. The firm is headquartered in Florence, Italy.

Innogest SGR SpA (Innogest) is a private equity firm founded in 2005 by Claudio Giuliano and Marco Pinciroli. The firm is headquartered in Milan, Italy.

Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona.

NeuroVascular Recovery Ltd. develops composite tissue implants.

EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy.

IGEA SpA is a holding company, which engages in the provision of clinical biophysics services. It develops orthopedic medical devices and oncological biophysics for the treatment of tumors. The company was founded by Ruggero Cadossi and Donata Marazzi in 1980 and is headquartered in Carpi, Italy.

IGEA '98 Srl provides real estate services. The private company is based in Rome, Italy.

STAT-Dx Life SL focuses on the development, manufacturing and commercialization of diagnostic solutions for fast and accurate diagnostic results of infectious diseases and critical care. It solution offers DiagCORE Cartridge, for sample and analyzation of cell material, nucleic acid purification, amplification and hybridization process. The company was founded by Jordi Cabrrera Fabra and Rafael Bru Gibert in 2010 and is headquartered in Barcelona, Spain.

Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US.

Medlumics SL provides medical imaging diagnostics services. It specializes in optically guided medical devices. The firm’s proprietary integrated optics platform technology combines optical and electrical components in a miniature chip, enabling for the first time complex multi view optical probes of the size of a grain of rice and ultra-portable, hand-held OCT systems that produces real-time images. The company was founded by Eduardo Margallo Balbás and Jose Luis Rubio Guivernau on April 3, 2009 and is headquartered in Tres Cantos, Spain.

Beintoo SpA develops and markets mobile engagement software solutions. The firm specializes in the design and operation of a customer engagement platform, offering loyalty programs to mobile users. The company was founded by Andrea Cozzi, Antonio Tomarchio, Walter Ferrara, William Nespoli, and Filippo Privitera on January 20, 2011 and is headquartered in Milan, Italy.

Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland.

Angiodroid SRL engages in the development and commercialization of medical devices. The firm specializes in the hemodynamics, vascular surgery and interventional radiology. It offers ANGIODROID CO2 injector, a carbon dioxide injector for peripheral interventional angiography and ANGIODROID CO2 single kit use for the injection of CO2 during an angiographic procedure. The company was founded by Sebastiano Zannoli and Samuele Zannoli in 2013 and is headquartered in San Lazzaro di Savena, Italy.

Pi-Cardia Ltd. develops catheter for the treatment of aortic stenosis. Its technology is based on delivering mechanical impact for creating fractures in valve calcifications, without injuring the surrounding soft tissue. The company was founded by Eyal Kolka and Erez Golan in 2009 and is headquartered in Rehovot, Israel.

BARD France SAS develops, manufactures, and distributes medical products and surgical equipment. The company is headquartered in Voisins-le-Bretonneux, Italy.

SoniVie Ltd. engages in the development of a system for the treatment of pulmonary hypertension. Its products include Therapeutic Intra-Vascular Ultrasound (TIVUS) system, an intravascular, catheter-based technology that can cause denervation of nerves surrounding blood vessels and other structures like the bronchus. The company was founded by Moshe Arkin in 2014 and is headquartered in Rosh Haayin, Israel.

D-Eye SRL design and manufacture mobile sensing and examination devices, along with companion applications. It enables mass health screenings and data collection to improve access to vital health examination services. The firm also develops cloud-based Platform-as-a-Service (PaaS) systems that will enable telehealth applications, and aggregate and analyze health screening data to provide insight into individual conditions as well as trends across patient populations. The company was founded by Andrea Russo in 2014 and it is headquartered in Padua, Italy.

Cuebiq, Inc. develops a mobile user engagement software platform. The company offers AudienceQ, VisitQ, InsightQ Audience, InsightQ Places and data monetization. The firm uses data intelligence platform to provide geo-behavioral insights and offline location analytics, geo-behavioral audiences for cross-platform ad targeting, and offline attribution analysis by observing and analyzing time spent by users at points of interest across the globe. The company was founded by Andrea Cozzi, Antonio Tomarchio, Filippo Privitera, Walter Ferrara, and William Nespoli and it is headquartered in New York, NY.

Newronika SRL manufactures medical and electro-medical equipment and appliances. It offers new adaptive deep brain stimulation systems for movement disorders (DBS); methods and devices for transcranial direct current stimulation (tDCS) represent the non-invasive neuromodulation activity. The company was founded by Priori Alberto and Lorenzo Rossi and is headquartered in Milan, Italy.

Cardiovascular Lab SpA provides health care services. The firm is a bridge between great ideas from physicians and international capital. The company was founded in 2016 and is headquartered in Turin, Italy.

Atricath SpA is a holding company, which engages in the research and development of technology for the treatment of atrial fibrillation. The company was founded by Enrico Perfler and is headquartered in Milan, Italy.

Part of Sienna Biopharmaceuticals, Inc., Creabilis UK Ltd. engages in research and development of biological products. The company is based in Canterbury, UK.

Bio4Dreams SpA (Bio4dreams) is a venture capital firm founded in 2017 by Pietro Conti, Laura Iris Ferro, Elisabetta Borello and Cusi Daniele. The firm is headquartered in Milan, Italy.

Asabys Partners SGEIC SA (Asabys Partners) is an independent venture capital firm founded in 2019 by Clara Campàs-Moya and Josep Lluís Sanfeliu Benet. The firm is headquartered in Barcelona, Spain.

Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY.

Chord Therapeutics SA is a clinical stage pharmaceutical company. It develops drugs for patients with rare, life-threatening and severely disabling diseases. The firm offers CRD1. The company was founded by Arthur Roach and is headquartered in Geneva, Switzerland.

EBAMed SA develops solutions for non-invasive and automated treatment of heart arrhythmias. The company was founded by Adriano Garonna and Leo Giovanni and is headquartered in Geneva, Switzerland.

EFI Lake Geneva Ventures ICAV (EFI Lake Geneva Ventures) is a venture capital firm founded in 2020 by Toby Main and Sandy Koifman. The firm is headquartered in Geneva, Switzerland.

Synendos Therapeutics AG develops molecules for the treatment of anxiety and stress-related disorders. The company was founded by Andrea Chicca, Simon Russell and Jürg Gertsch in April 2019 and is headquartered in Allschwil, Switzerland.

LiftT SpA (LiftT) is a venture capital firm founded in 2019. The firm is headquartered in Turin, Italy.

CDR-Life Inc. is a Swiss biotherapeutics company that develops novel immunotherapies to target the power of the immune system specifically to tumor cells. CDR-Life is based in Schlieren, Switzerland, and was founded in 2017 by Leonardo Borras, Christian Leisner, Dominik Escher, Rouven Bingel-Erlenmeyer, and Konstantin von Schulthess. The company's proprietary antibody platform targets intracellular tumor antigens presented on the major histocompatibility complex (MHC) with high affinity and specificity, which allows them to develop a pipeline of first-in-class therapeutics across a broad range of solid tumors. The company is backed by leading cross-Atlantic investors and has an existing collaboration and licensing agreement with Boehringer Ingelheim for a novel antibody fragment therapy to treat macular degeneration. Christian Leisner has been the CEO since 2017.

NRG Therapeutics Ltd. is a British neuroscience drug discovery company that focuses on building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and ALS. The company is based in Stevenage, UK, and was founded in 2018 by Neil Miller and Richard Rutter. The company's pre-clinical pipeline of small molecule assets is based on inhibiting the mitochondrial permeability transition pore (mptp) through a novel mechanism of action. Inhibition of the mptp has been shown to protect neurons, reduce neuroinflammation, and extend survival in pre-clinical disease models. Neil Miller has been the CEO since 2018.

Medyria AG develops technologies for endovascular catheter navigation and sensing. Its products include trackcath, flowcath and OEM flow sensor. The firm's technology is a sensor-based system combined with a novel approach for processing flow data and tracking catheters. The targeted medical domains comprise vascular, valve, and heart procedures. The company's products increase accuracy reducing complications and risks, fostering the conversion from open surgery to minimally invasive approach. Medyria was founded by Mauro Massimo Sette in 2012 and is headquartered in Winterthur, Switzerland.